GSTM4 and Ewing sarcoma: Additionally, the previous study has found that GSTM4 expression level affects the oncogenic and drug-resistant properties of Ewing’s sarcoma cells [65] provides a relevant precedent for investigating the potential of GSTM4 as a therapeutic target in migraine.